Pages that link to "Q69966783"
Jump to navigation
Jump to search
The following pages link to Chronic valproic acid therapy and incidence of increases in venous plasma ammonia (Q69966783):
Displaying 12 items.
- Valproic acid-associated encephalopathy (Q28331564) (← links)
- Valproate-induced hyperammonemic encephalopathy (Q35071872) (← links)
- Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy (Q36193367) (← links)
- The measurement of ammonia blood levels in patients taking valproic acid: looking for problems where they do not exist? (Q36936475) (← links)
- Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes (Q38682728) (← links)
- Clinical pharmacokinetics of valproic acid--1988. (Q39609802) (← links)
- Diet- and valproate-induced transient hyperammonemia: effect of l-carnitine (Q51575416) (← links)
- Hyperammonemia secondary to valproic acid as a cause of lethargy in a postictal patient (Q52037855) (← links)
- Free and total serum valproate concentrations: their relationship to seizure control, liver enzymes and plasma ammonia in children (Q70301643) (← links)
- Lack of relationship between sodium valproate-induced adverse effects and the plasma concentration of its metabolite 2-propylpenten-4-oic acid (Q70341112) (← links)
- Asymptomatic Hyperammonemia in Children Treated With Valproic Acid (Q73888062) (← links)
- Blood Ammonia Levels in Epileptic Children on 2 Dose Ranges of Valproic Acid Monotherapy: A Cross-Sectional Study (Q85156771) (← links)